+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Thoracic Drainage Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon

    Report

  • 115 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4896251

Thoracic drainage devices are designed to remove air, liquids, and some solids from the pleural space of chest. Factors such as rising demand for minimally invasive surgeries, high prevalence of cardiovascular diseases and increase in burden of spontaneous pneumothorax are driving the growth of the thoracic drainage devices market. The rise in demand for minimally invasive procedures over open surgery is triggering a high market growth rate. Also, these procedures usually provide equivalent outcomes to traditional open surgery, along with offering significant benefits, like lower risk of complications, shorter length of stay, and lesser recuperation period. Furthermore, reducing healthcare costs involved in undergoing a minimally invasive procedure when compared to the normal surgical procedure has also been an instrumental factor driving the market growth. Hence, there is increasing care provider's preference for minimally invasive procedures for a range of surgical applications which is expected to boost the demand for thoracic drainage devices worldwide.



Key Market Trends


Thoracic Surgery & Pulmonology Segment is Expected to Register a Significant Growth in the Forecast Years


By Application, the market has been segmented into Cardiac Surgery, Oncology & Pain Management, Thoracic Surgery & Pulmonology, General Intensive Care Emergency Medicine and Others. Thoracic and pulmonological disorders are quite common and the prevalence of these disorders is increasing as compared to other applications and this trend is expected to continue over the forecast period. As per the U.S. Census and the Society of Thoracic Surgery, in 2010 there were approximately 4,000 cardiothoracic surgeons who performed more than 530,000 cases. By 2030, it is expected that there will be about 3,000 cardiothoracic surgeons available to cover about 854,000 cases. The average case-load per surgeon will increase from 135 in 2010 to 299 in 2035 because of the high population growth. Thoracic drainage devices are used in the treatment of pneumothorax, pleural effusions, and empyema disorders. In addition, growing public awareness and a large patient pool also contributes to the growth of the studied market.



North America leads the Thoracic Drainage Devices Market


North America is expected to lead the market, owing to high standards of healthcare infrastructure and easy availability of sophisticated technology in this region. This is primarily attributed to rising incidences of chronic diseases as well as higher healthcare expenditure in countries in the region. According to the American College of Cardiology, cardiovascular disease (CVD) accounted for 800,000 deaths in the United States in 2017 alone. Among Americans, an average of one person dies from cardiovascular disease, every 40 seconds. Europe and the Asia Pacific are followed next after North America owing to rising patient population, growth of healthcare industry and increase in the number of surgeries in the region, thus driving this market.



Competitive Landscape


The major players in the thoracic drainage devices market includes ATMOS MedizinTechnik GmbH & Co. KG, Becton, Dickinson and Company, Cardinal Health, Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Smiths Group plc, Teleflex Incorporated, Utah Medical Products, Inc. and Vygon SA.



Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally Invasive Surgeries
4.2.2 High Prevalence of Cardiovascular Diseases
4.2.3 Increase Demand of Early Diagnosis and Treatment of Diseases
4.3 Market Restraints
4.3.1 Lack of Availability of Skilled Physicians
4.3.2 Stringent Regulatory Guidelines
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Thoracic Drainage Systems
5.1.2 Thoracic Drainage Kits
5.1.3 Pleural Drainage Catheters
5.1.4 Trocar Drains
5.1.5 Others
5.2 By Application
5.2.1 Cardiac Surgery
5.2.2 Oncology & Pain Management
5.2.3 Thoracic Surgery & Pulmonology
5.2.4 General Intensive Care Emergency Medicine
5.2.5 Others
5.3 By End-User
5.3.1 Hospitals & Clinics
5.3.2 Ambulatory Surgery Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ATMOS MedizinTechnik GmbH & Co. KG
6.1.2 Becton, Dickinson and Company
6.1.3 Cardinal Health
6.1.4 Cook Group Incorporated
6.1.5 Getinge AB
6.1.6 Sinapi Biomedical
6.1.7 Smiths Group plc
6.1.8 Teleflex Incorporated
6.1.9 Utah Medical Products, Inc.
6.1.10 Vygon SA
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ATMOS MedizinTechnik GmbH & Co. KG
  • Becton, Dickinson and Company
  • Cardinal Health
  • Cook Group Incorporated
  • Getinge AB
  • Sinapi Biomedical
  • Smiths Group plc
  • Teleflex Incorporated
  • Utah Medical Products, Inc.
  • Vygon SA

Methodology

Loading
LOADING...